BANK VONTOBEL/PUT/ROCHE GS/200/0.05/20.12.24 Share Price

Warrant

WROBGV

CH1312997542

Market Closed - Swiss Exchange 16:20:00 24/06/2024 BST
0.094 CHF -12.96% Intraday chart for BANK VONTOBEL/PUT/ROCHE GS/200/0.05/20.12.24
Current month-52.53%
1 month-53.47%
Date Price Change
24/06/24 0.094 -12.96%
21/06/24 0.108 -5.26%
20/06/24 0.114 -1.72%
19/06/24 0.116 -12.12%
18/06/24 0.132 -1.49%

Delayed Quote Swiss Exchange

Last update June 24, 2024 at 04:20 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WROBGV
ISINCH1312997542
Date issued 16/01/2024
Strike 200 CHF
Maturity 20/12/2024 (178 Days)
Parity 20 : 1
Emission price 0.2 CHF
Emission volume N/A
Settlement physique
Currency CHF

Technical Indicators

Highest since issue 0.405 CHF
Lowest since issue 0.094 CHF
Delta-0.08x
Omega 10.96
Premium21.81x
Gearing136.24x
Moneyness 0.7893
Difference Strike -53.4 CHF
Difference Strike %-26.70%
Spread 0.01 CHF
Spread %10.20%
Theoretical value 0.0930
Implied Volatility 26.66 %
Total Loss Probability 88.80 %
Intrinsic value 0.000000
Present value 0.0930
Break even 198.14 CHF
Theta-0.01x
Vega0.01x
Rho-0.01x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
253.4 CHF
Average target price
278.1 CHF
Spread / Average Target
+9.73%
Consensus
  1. Stock Market
  2. Warrants
  3. WROBGV Warrant